Kymera Therapeutics, Inc. (KYMR) Revenue History
Kymera Therapeutics, Inc. (KYMR) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | $34.03M |
| 2021-12-31 | $72.83M |
| 2022-12-31 | $46.83M |
| 2023-12-31 | $78.59M |
| 2024-12-31 | $47.07M |
| 2025-12-31 | $39.21M |
How KYMR compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc. | $65.32M |
| AGIO | Agios Pharmaceuticals Inc. | $54.03M |
| LXRX | Lexicon Pharmaceuticals Inc. | $49.80M |
| GOSS | Gossamer Bio Inc. | $48.47M |
| VSTM | Verastem Inc. | $30.91M |
These are five companies in the same sector as KYMR with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Kymera Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("KYMR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | KYMR | $125.55 | -0.86% | 0.53M |
| 3 | ||||
| 4 | ||||
| 5 |